Clinical trial
Pan-European Proof-of-concept Study Comparing Decentralised Clinical Trial (DCT) and Hybrid Approaches to Conventional Clinical Trial Approaches in Patients With Type 2 Diabetes Mellitus Treated With Toujeo®
NCT05780151 is registered in ClinicalTrials.gov with Mira Zuidgeest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pan-European Proof-of-concept Study Comparing Decentralised Clinical Trial (DCT) and Hybrid Approaches to Conventional Clinical Trial Approaches in Patients With Type 2 Diabetes Mellitus Treated With Toujeo®
- Lead sponsor
- Mira Zuidgeest
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 10, 2023
- Completion date
- January 21, 2025
- Enrollment
- 107 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.